Etrixenal 250 mg tablety Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

etrixenal 250 mg tablety

proenzi, s.r.o., Česká republika - naproxén - 29 - antirheumatica, antiphlogistica, antiuratica

Parapyrex Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

parapyrex

dr. max pharma s.r.o., Česká republika - paracetamol - 07 - analgetica, antipyretica

ADNEBOL 500 mg Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

adnebol 500 mg

adamed pharma s.a., poľsko - naproxén - 29 - antirheumatica, antiphlogistica, antiuratica

Coldrex Grip plus kašeľ s príchuťou citrónu a mentolu Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

coldrex grip plus kašeľ s príchuťou citrónu a mentolu

omega pharma a.s., Česká republika - paracetamol, kombinácie s výnimkou psycholeptík - 07 - analgetica, antipyretica

Parastad mäkké kapsuly Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

parastad mäkké kapsuly

stada arzneimittel ag, nemecko - paracetamol - 07 - analgetica, antipyretica

Coxtral Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

coxtral

zentiva k.s., Česká republika - nimesulid - 29 - antirheumatica, antiphlogistica, antiuratica

Clopidogrel Acino Uni Eropa - Slovak - EMA (European Medicines Agency)

clopidogrel acino

acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotické činidlá - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.